Quotient Clinical delivers breakthrough first-in-human program for Corcept Therapeutics

15-Jun-2015 - Quotient Clinical has announced the successful completion of an Enabled-First-in-Human® (Enabled-FIH) program for Corcept Therapeutics Incorporated, focusing on a next generation selective glucocorticoid receptor antagonist (CORT125134) in development for the treatment of Cushing’s syndrome and ...

Quotient Clinical and Bend Research Announce Collaboration To Accelerate Advancement of New Medicines

15-Nov-2010 - Bend Research Inc. and Quotient Clinical, a business unit of Quotient Bioresearch, announced a nonexclusive collaboration that can speed the advance of compounds to clinical trials and expand options for drug delivery. The collaboration combines Bend Research’s advanced drug formulation ...

Quotient Bioresearch Celebrates Official Opening of New State-of-the-Art Radiochemistry Facility

15-Sep-2010 - Quotient Bioresearch has officially opened its new, state-of-the-art radiochemistry facility in Cardiff, UK, with a ceremony including a VIP opening by the First Minister of Wales, Carwyn Jones. The new facility, which has been named “The Old Glassworks”, represents a £15 Million investment for ...

Quotient Bioresearch's New Radiochemistry Facility Fully Operational

23-Jun-2010 - Quotient Bioresearch announced that its new, state-of-the-art radiochemistry facility in Cardiff, UK is fully operational and that shipments of radiolabelled products have commenced. All staff have successfully transferred from the former site operated by Amersham Radiolabelling Services to the ...

Clinical Reference Laboratory Inc to build European laboratory hub in UK

25-Aug-2009 - Clinical Reference Laboratory Inc has concluded a deal with Quotient Bioresearch that will see CRL Global Services establish its new European laboratory hub in the UK. CRL Global Services has a track record of more than 18 years in delivering testing services to support clinical development ...

Quotient Clinical Receives MHRA Supplementary Accreditation

08-Jul-2009 - Quotient Clinical announces that it has been awarded Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA). This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform the full range of Phase I ...

Quotient Bioresearch acquires radiochemical custom synthesis operations from GE Healthcare

Major investment in new radiochemicals facility to be located in Cardiff, Wales

30-Jun-2009 - Quotient Bioresearch Limited announced that it has reached an agreement to acquire Amersham Radiolabelling Services, the radiochemical custom synthesis operations of GE Healthcare. This represents Quotient’s seventh acquisition since its formation in early 2007. According to the company, this ...